Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 28-sep-2026 · last seen 28-sep-2026

Asb2–KIF11 Axis in Cardiomyocyte Autophagy and Cardiac Aging

Current understanding

Asb2 is a cullin-RING E3 ligase adaptor proposed to protect the aging and pressure-overloaded heart by ubiquitin-mediated degradation of the kinesin KIF11, thereby restoring perinuclear lysosomal distribution, late-stage autophagic flux, and mitochondrial quality control in adult cardiomyocytes; genetic Asb2 restoration and pharmacologic KIF11 inhibition reverse age-related and pressure-overload cardiac remodeling in mice [animal-model]. Human-translation status: no human evidence; KIF11 inhibitors exist as oncology agents but have not been tested for cardiac-aging endpoints.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical
Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis.
22-sep-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18